Company Overview

Harnessing the power of fully human domain antibody (UDAB™)to fight disease: At Biomissile, we discover and develop multi-specific therapeutic antibodies to fight a wide range of diseases, especially in areas where there are no effective therapies.

Read More
Strong Pipeline:

A therapeutic pipeline of more than 10 innovative biologics, including several first-in-class fully human domain antibody-based bi- and multi-specifics
(UDAB-MTM).

Our Vision:

To become a premium innovative biopharmaceutical company based on our unique platform technologies, strong pipeline, and outstanding team.

Suzhou: GMP

Suzhou: GMP

Shanghai: Discovery

Shanghai: Discovery

Boston: BD & Regulatory

Boston: BD & Regulatory

Management Team

2023-01-30
Co-founder, President & CEO
2023-01-30
Co-founder & CSO
2023-01-30
CFO
2023-01-30
VP, Discovery Head
2023-01-30
VP, Head of CMC
2023-01-30
VP, BD and Alliance Management
2024-02-18
Executive Director, Clinical Research
2024-09-19
Executive Director, R&D

Scientific Advisors

2023-01-30
Co-founder & Scientific Advisor
2023-01-30
Scientific Advisor